Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals

Sponsor
St. Jude Children's Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03581045
Collaborator
(none)
92
1
42.5
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if adult survivors of childhood Acute Lymphoblastic Leukemia (ALL) enrolled on the SJLife (St. Jude Life) protocol are at increased risk for postural control deficits compared to individuals with no cancer history. All participants will be assessed for their ability to maintain an upright posture, walk at their usual speed, and to tandem walk, all while engaged in a cognitive task.

Primary Objective

To compare changes in postural control in ALL survivors to changes in postural control in healthy controls, matched on age- and sex- in simple versus complex standing and walking activities (complex: standing or walking with added cognitive load).

Secondary Objective

To identify demographic and performance related risk factors for decreased postural control during complex standing or walking activities in survivors and controls and to evaluate associations between treatment and the changes in postural control during complex activities among survivors.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Cognitive performance (attention and working memory) will be evaluated using the auditory N-Back test. The 0-back condition and the 2-back condition will be used. After cognitive assessment, participants will perform 3 different postural control tasks (standing balance, regular gait, and tandem gait) in a random order. Postural tasks for each participant will be determined by using random allocation envelopes.

    Computerized dynamic posturography will be used to evaluate standing balance with no added cognitive load. Standing balance assessment will be repeated two more times, once with participants engaged in performing the auditory 0-back task, and then with simultaneously performing the auditory 2-back task. Regular gait at participants' preferred speed will be examined using 6 light-weight wearable inertial sensors. The regular walking assessment will be repeated with simultaneous performance of the 0-back task and then with simultaneous engagement in the 2-back task. We have also included a tandem gait (placing one foot directly in front of the other) in order to make the postural task more challenging. The wearable inertial sensors will be used to record participants' gait characteristics while tandem walking. The tandem walk assessment will be repeated once with the participant simultaneously perform the 0-back task and then with the 2-back task. The estimated required time to perform all of the assessments and with inclusion of 3 rest intervals is 2 hours.

    In addition, data from the overall SJLIFE assessment will be used in analysis.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    92 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Cross-Sectional
    Official Title:
    Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals
    Actual Study Start Date :
    Oct 2, 2018
    Actual Primary Completion Date :
    Feb 2, 2020
    Actual Study Completion Date :
    Apr 17, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    ALL Survivors

    Adult survivors of Acute Lymphoblastic Leukemia (ALL) enrolled on the SJLIFE protocol

    Control Group

    Healthy Individuals with no history of childhood or adult onset cancer, matched on age- and sex

    Outcome Measures

    Primary Outcome Measures

    1. Regular gait speed [Up to 1 hour]

      Regular gait will be evaluated in three different testing conditions: regular gait assessment while participants are engaged in performing a challenging cognitive task (2-back), regular gait assessment while participants are engaged in performing an easy cognitive task (0-bak) and regular gait assessment with no additional cognitive load (baseline). In each condition, the difference in gait speed of each survivor and his/her matched control will be obtained. Then the obtained differences at regular gait assessment with no additional cognitive load (baseline) and regular gait while performing the challenging cognitive task (2-bck) will be compared using a paired t-test.

    2. Composite score from standing balance test [Up to 1 hour]

      Standing balance ability will be examined in three different testing conditions: standing balance while participants are engaged in performing a challenging cognitive task (2-back), standing balance while participants are engaged in performing an easy cognitive task (0-back), and standing balance assessment with no additional cognitive load. In each condition, the difference in composite score of each survivor and his/her matched control will be obtained. Then the obtained differences at standing balance assessment with no additional cognitive load (baseline) and standing balance assessment while performing the challenging cognitive task (2-back) will be compared using a paired t-test.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 39 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria - Cases:
    • Diagnosis of childhood ALL

    • At least 5 years post ALL diagnosis

    • No history of secondary malignancies after an ALL diagnosis

    • Enrollment on the SJLIFE protocol

    • Ages 18.00 to 39.99

    • Ability to stand and walk for 20 seconds or more

    • Ability to answer the eligibility questions

    • Ability to provide informed consent

    Inclusion Criteria - Controls:
    • No history of childhood or adult onset cancer

    • Enrollment on the SJLIFE protocol

    • Ages 18.00 to 39.99

    • Ability to stand and walk for 20 seconds or more

    • Ability to answer the eligibility questions

    • Ability to provide informed consent

    Inclusion of Women and Minorities:

    • Male and females of all races and ethnic groups are eligible

    Exclusion Criteria:
    • Currently receiving treatment for cancer

    • Weight ≥ 300 lb (the balance system has a weight limit)

    • Does not speak English

    • Self-reports of hearing issues

    • Pregnant females

    • Inability or unwillingness of research participant to give written informed consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 St. Jude Children's Research Hospital Memphis Tennessee United States 38105

    Sponsors and Collaborators

    • St. Jude Children's Research Hospital

    Investigators

    • Principal Investigator: Kristen K Ness, PhD, St. Jude Children's Reearch Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    St. Jude Children's Research Hospital
    ClinicalTrials.gov Identifier:
    NCT03581045
    Other Study ID Numbers:
    • PCALL
    • NCI-2018-01471
    First Posted:
    Jul 10, 2018
    Last Update Posted:
    Apr 26, 2022
    Last Verified:
    Apr 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by St. Jude Children's Research Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 26, 2022